Written by Christopher Liew, CFA at The Motley Fool Canada
Artificial intelligence (AI) is responsible for solving complex problems and carrying out tasks performed by humans. While adoption is already reaching peaks in the technologyfrom finance, manufacturing and retail, the Canadian health technology landscape is poised for a similar transformation.
With adoption expected to increase from moderate to very high, investors should include GOOD Health Technologies (Toronto Stock Exchange: GOOD), Healwell AI (Toronto Stock Exchange: AIDX), And VitalHub (TSX: VHI) on their watch lists. These three companies are expected to be the main drivers of the AI revolution in healthcare in 2026.
WELL Health Technologies is an aggressive AI game, if not the mothership of AI in healthcare. The billion-dollar digital health technology company owns and operates primary health care locations in Canada and the United States. It provides electronic medical record (EMR) services as software as a solution (SaaS) to Canadian clinics and physicians, as well as virtual care and patient engagement solution providers.
Its founder, president and CEO, Hamed Shabazi, said: “Over the past several years, we have significantly grown WELL’s business and strengthened our leadership position as Canada’s preeminent end-to-end healthcare company, while our U.S. businesses continue to thrive in their respective sectors.
Healthcare providers can join the WELL health clinic network or purchase technology solutions. Either way, the result should be improved clinic efficiency and health outcomes.
Through the first three quarters of 2025, revenue grew 48% year-over-year to $1 billion, while operating profit reached $51.9 million, compared to an operating loss of $5.1 million a year ago. WELL has increased its ability to deliver the best in vendor-driven technologies following two strategic acquisitions.
In addition to North America, WELL can deliver on a large scale to large enterprise and public sector customers in Australia, France, New Zealand, Spain, Saudi Arabia, the United Kingdom and the United Arab Emirates.
WELL Health owns a 69% interest in Healwell AI. The $272 million healthcare AI company focuses on preventative care. She develops tools to help healthcare providers detect rare and chronic diseases. The two major segments, AI, data science and healthcare software, work together to advance healthcare for patients.
Market analysts say Healwell is an alternative to purchasing the entire WELL Health ecosystem. Instead, you would invest in a company purely focused on AI diagnostics. Regarding the stock price, WELL and AIDX are trading at $3.99 and $0.87 per share, respectively.